Amrutanjan Health Care Limited (NSE:AMRUTANJAN)
753.40
+3.10 (0.41%)
Sep 19, 2025, 10:30 AM IST
Amrutanjan Health Care Revenue
Amrutanjan Health Care had revenue of 940.46M INR in the quarter ending June 30, 2025, with 12.31% growth. This brings the company's revenue in the last twelve months to 4.62B, up 8.23% year-over-year. In the fiscal year ending March 31, 2025, Amrutanjan Health Care had annual revenue of 4.52B with 7.26% growth.
Revenue (ttm)
4.62B
Revenue Growth
+8.23%
P/S Ratio
4.69
Revenue / Employee
6.27M
Employees
737
Market Cap
21.68B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 4.52B | 305.93M | 7.26% |
Mar 31, 2024 | 4.21B | 416.12M | 10.96% |
Mar 31, 2023 | 3.80B | -261.89M | -6.45% |
Mar 31, 2022 | 4.06B | 729.35M | 21.90% |
Mar 31, 2021 | 3.33B | 712.64M | 27.23% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Aurobindo Pharma | 320.25B |